CNEY Receives NASDAQ Minimum Bid Price Requirement Extension LISHUI, China, Dec. 4, 2024 /PRNewswire/ — CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY"… CISION PRNewswireDecember 4, 2024
Press ReleaseAppian Unveils Latest Platform Release for Better Process and Better Outcomes New enhancements scale high-volume workflows and increase efficiency and analysis with AI… CISION PRNewswireDecember 4, 2024
Half of Australians live with chronic health conditions, over a third forced to leave their jobs as a result Patient advocates call for more support for Australian workers living with a… CISION PRNewswireDecember 4, 2024
Dunxin Financial Holdings Limited Announces Planned ADS Ratio Change HONG KONG, Dec. 4, 2024 /PRNewswire/ — Dunxin Financial Holdings Limited ("Dunxin" or… CISION PRNewswireDecember 4, 2024
Press ReleaseAsia's Transformative Era: Unveiling the "Asian Dream" through New Study "Truth About Ascending Asia" SINGAPORE, Dec. 4, 2024 /PRNewswire/ — McCann Worldgroup has launched its latest… CISION PRNewswireDecember 4, 2024
China Clean Expo 2025, Taking Your Cleaning Business to a New Height! SHANGHAI, Dec. 4, 2024 /PRNewswire/ — 26th China Clean Expo (CCE), organized… CISION PRNewswireDecember 4, 2024
Press ReleaseHublot celebrates the 25th Anniversary of OpusX with a special edition Classic Fusion Chronograph CLASSIC FUSION CHRONOGRAPH ARTURO FUENTE KING GOLD To stay up-to-date, follow: @Hublot #Hublot… CISION PRNewswireDecember 4, 2024
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and… CISION PRNewswireDecember 3, 2024
